Revealing the influence of glucocorticoid treatment on the excretion of anabolic-androgenic steroids in horses through in vitro digestive simulations and an in vivo case study.
- Journal Article
Summary
This research investigates the effect of glucocorticoid treatment, a common anti-inflammatory therapy, on the excretion of anabolic-androgenic steroids (AAS) in horses. The study confirms that treatment disrupts AAS synthesis and excretion, not via direct digestion transformation, but likely through impacts on the hypothalamic-pituitary-adrenal axis.
Overview
The study endeavours to explore the potential correlation between glucocorticoid treatment and the excretion of AAS in horses. Anabolic-androgenic steroids are banned in equestrian sports due to their enhancement effects on muscle growth and performance. However, they’ve been detected in some horses – that haven’t been treated with AAS – implying a possible role of glucocorticoids, which are related to AAS structurally and used for anti-inflammatory therapy, in this phenomenon.
In vivo and In vitro Exploration
- The researchers studied the influence of glucocorticoid treatment on AAS excretion both in vitro (through simulated digestion) and in vivo (using a treated gelding).
Analytical Techniques
- They utilized UHPLC-MS/MS and UHPLC-Orbitrap-HRMS methods for analysis of the urine and in vitro digestion samples.
Findings
- The treatment resulted in a significant influence on the urinary excretion of α-testosterone, β-testosterone, and androsta-1,4-diene-3,17-dione (ADD).
- Post-treatment, αT-concentrations were detected up to 20ng/mL and ADD, not present pre-treatment, could be detected.
- Levels of cortisone and cortisol also increased markedly between days 37 and 48 post-treatment.
Conclusion
- Despite the in vitro digestion results ruling out direct biotransformation of glucocorticoids to AAS by the microbiota of the equine hindgut, the study confirmed a disruption to the synthesis and excretion of AAS through glucocorticoid treatment.
- This disruption is likely not caused by direct gastrointestinal digestion transformation, but rather by influencing the hypothalamic-pituitary-adrenal axis.
Cite This Article
Publication
Researcher Affiliations
- Ghent University, Laboratory of Chemical Analysis, Faculty of Veterinary Medicine, Department of Veterinary Public Health and Food Safety, 133 Salisburylaan, B-9820 Merelbeke, Belgium; Ghent University, Laboratory of Biochemistry and Brewing, Faculty of Bioscience Engineering, Department of Applied Biosciences, 1 Valentin Vaerwyckweg, B-9000 Ghent, Belgium.
- Ghent University, Laboratory of Chemical Analysis, Faculty of Veterinary Medicine, Department of Veterinary Public Health and Food Safety, 133 Salisburylaan, B-9820 Merelbeke, Belgium.
- Ghent University, Laboratory of Chemical Analysis, Faculty of Veterinary Medicine, Department of Veterinary Public Health and Food Safety, 133 Salisburylaan, B-9820 Merelbeke, Belgium. Electronic address: Lynn.Vanhaecke@ugent.be.
MeSH Terms
- Anabolic Agents / pharmacokinetics
- Androstadienes
- Animals
- Biotransformation
- Digestion / physiology
- Drug Interactions
- Glucocorticoids / pharmacokinetics
- Glucocorticoids / pharmacology
- Horses / metabolism
- Hypothalamo-Hypophyseal System / chemistry
- Pituitary-Adrenal System / chemistry
- Sports
- Steroids / metabolism
- Tandem Mass Spectrometry
- Testosterone / metabolism
Citations
This article has been cited 1 times.- Vandana UK, Barlaskar NH, Gulzar ABM, Laskar IH, Kumar D, Paul P, Pandey P, Mazumder PB. Linking gut microbiota with the human diseases.. Bioinformation 2020;16(2):196-208.